Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Peptide Mix Makes HIV Self-Destruct in a Petri Dish

By LabMedica International staff writers
Posted on 07 Sep 2010
A new study describes a peptide cocktail that causes apoptotic cell death of HIV infected cells, with total extermination of the virus.

Researchers at the Hebrew University (Jerusalem, Israel) developed a novel approach to eradicate HIV-1 infected cells specifically and significantly, as well as to eliminate infectious virions from cultured cells. More...
The process involves the stimulation of viral integrase (IN) enzymatic activity by the IN derived-integrase stimulatory (INS) peptide and IN derived-Rev interacting (INrs) peptides to disrupt the IN complex, combined with the prevention of virion production by the protease inhibitor Ro 31-8959.

The researchers found a correlation between increase in the integration of HIV-1 cDNA and cell death, showing that the combination of peptides that stimulate integration, together with the protease inhibitor caused apoptotic cell death of the HIV infected cells. This combination did not have any effect on noninfected cells, appearing to promote cell death only in infected cells. The researchers suggest that the results could provide a novel approach to promote the death of HIV-1 infected cells specifically, and may eventually be developed into a new and general antiviral therapy. The study was published on august 19, 2010, in Aids Research and Therapy, a publication of Biomed Central.

"Whilst this research is promising, a major caveat with these studies is that they are preliminary,” said lead author Abraham Loyter, Ph.D., of the department of biological chemistry. "So far these experiments have only been shown to 'cure' HIV from small dishes of cultured cells in the authors' laboratory, but the findings are an exciting development in the quest to eradicate this devastating global pandemic.”

A virion consists of a complete virus particle, composed of nucleic acid surrounded by a protective coat of protein called a capsid; these are formed from identical protein subunits called capsomers. One of the problems with battling HIV is that it evades the immune system by constantly changing the amino acid sequence of the proteins on the surface of the virion.

Since most viruses cannot be seen with a light microscope, scanning and transmission electron microscopes are used to visualize the virion.

Related Links:

Hebrew University



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.